Bas D. Koster

567 citations
19 papers · 406 · h-index 9

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • T-cell and B-cell Immunology
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

  • Immunology 13
    • Immunotherapy and Immune Responses 12
    • T-cell and B-cell Immunology 3
    • Immune Cell Function and Interaction 2
  • Oncology 11
    • Cancer Immunotherapy and Biomarkers 9
    • CAR-T cell therapy research 8
    • Cutaneous Melanoma Detection and Management 2
Co-authors
Tanja D. de Gruijl (13 shared papers)Alfons J.M. van den Eertwegh (8 shared papers)Ekaterina S. Jordanova (2 shared papers)A. Marijne Heeren (3 shared papers)Rik J. Scheper (7 shared papers)Mari F.C.M. van den Hout (7 shared papers)Barbara G. Molenkamp (6 shared papers)Berbel J.R. Sluijter (7 shared papers)
Journals
Cancer Immunology Research (3 papers)Cancer Immunology Immunotherapy (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Clinical Cancer Research (1 paper)Blood (1 paper)
Partner nations
NetherlandsUnited StatesGermany

In The Last Decade

Bas D. Koster

19 papers receiving 403 citations

Peers

Bas D. Koster
Comparison fields: 5 of 50
  • Immunology 280
  • Oncology 273
  • Obstetrics and Gynecology 24
  • Cancer Research 29
  • Immunology and Allergy 10
Replace Jossie Rotman with:
Jossie Rotman Netherlands
Joyce M. Lubbers Netherlands
Mei Cao China
Cécile Déjou France
M. N. Stakheyeva Russia
Hila Razon Israel
Valeria Visconti Italy
Diana Handke Germany
Boyeong Song South Korea
Apostolos C Ziogas Greece
Bas D. Koster relative to Jossie Rotman Netherlands Jossie Rotman's profile →
Citations per field
00.5×2×3×4.1×
Jossie Rotman · 1×
Citations per year

Countries citing papers authored by Bas D. Koster

Since Specialization
Citations

This map shows the geographic impact of Bas D. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas D. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas D. Koster more than expected).

Fields of papers citing papers by Bas D. Koster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas D. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas D. Koster. The network helps show where Bas D. Koster may publish in the future.

Co-authors

The 25 scholars most cited alongside Bas D. Koster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bas D. Koster Line = papers co-authored together Bas D. Koster links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
Cancer Immunology Research ·A. Marijne Heeren, Bas D. Koster, Sanne Samuels, Debbie M. Ferns, Dafni Chondronasiou, Gemma G. Kenter, Ekaterina S. Jordanova, Tanja D. de Gruijl
201495
2
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
Cancer Immunology Immunotherapy ·Jossie Rotman, Bas D. Koster, Ekaterina S. Jordanova, A. Marijne Heeren, Tanja D. de Gruijl
201957
3
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I–II Melanoma: Data from Two Randomized Phase II Trials
Clinical Cancer Research ·Bas D. Koster, Mari F.C.M. van den Hout, Berbel J.R. Sluijter, Barbara G. Molenkamp, Ronald J.C.L.M. Vuylsteke, Arnold Baars, Paul A.M. van Leeuwen, Rik J. Scheper, M. Petrousjka van den Tol, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl
201754
4
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141+ Dendritic Cells and Enhanced Cross-Presentation
Cancer Immunology Research ·Berbel J.R. Sluijter, Mari F.C.M. van den Hout, Bas D. Koster, Paul A.M. van Leeuwen, Famke L. Schneiders, Rieneke van de Ven, Barbara G. Molenkamp, Saskia Vosslamber, Cornelis L. Verweij, M. Petrousjka van den Tol, Alfons J.M. van den Eertwegh, Rik J. Scheper, Tanja D. de Gruijl
201550
5
Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence
Cancer Immunology Research ·Mari F.C.M. van den Hout, Bas D. Koster, Berbel J.R. Sluijter, Barbara G. Molenkamp, Rieneke van de Ven, Alfons J.M. van den Eertwegh, Rik J. Scheper, Paul A.M. van Leeuwen, M. Petrousjka van den Tol, Tanja D. de Gruijl
201737
6
Local delivery of low-dose anti–CTLA-4 to the melanoma lymphatic basin leads to systemic T reg reduction and effector T cell activation
Science Immunology ·Kim M. van Pul, Jessica C.L. Notohardjo, Marieke F. Fransen, Bas D. Koster, Anita G.M. Stam, Dafni Chondronasiou, Sinéad M. Lougheed, Joyce Bakker, Vinitha Kandiah, M. Petrousjka van den Tol, Karin Jooss, Ronald J.C.L.M. Vuylsteke, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl
202231
7
Recent developments and future challenges in immune checkpoint inhibitory cancer treatment
Current Opinion in Oncology ·Bas D. Koster, Tanja D. de Gruijl, Alfons J.M. van den Eertwegh
201523
8
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
Cancer Immunology Immunotherapy ·Bas D. Koster, Saskia J. Santegoets, Jorien Harting, Arnold Baars, S. Marieke van Ham, Rik J. Scheper, Erik Hooijberg, Tanja D. de Gruijl, Alfons J.M. van den Eertwegh
201919
9
T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A+CD141+ cDC1 and CD14+ antigen-presenting cell recruitment
Journal for ImmunoTherapy of Cancer ·Bas D. Koster, Marta López González, Mari F.C.M. van den Hout, Annelies W. Turksma, Berbel J.R. Sluijter, Barbara G. Molenkamp, Paul AM van Leeuwen, Saskia Vosslamber, Rik J. Scheper, Alfons JM van den Eertwegh, M. Petrousjka van den Tol, Ekaterina J Jordanova, Tanja D. de Gruijl
202118
10
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma
OncoImmunology ·Bas D. Koster, Tamarah D. de Jong, Mari F.C.M. van den Hout, Berbel J.R. Sluijter, Ronald J.C.L.M. Vuylsteke, Barbara G. Molenkamp, Saskia Vosslamber, M. Petrousjka van den Tol, Alfons J.M. van den Eertwegh, Tanja D. de Gruijl
20197
11
[Fatal poisoning caused by aconite monk's hood (Aconitum napellus)].
PubMed ·Axel Feldkamp, Bas D. Koster, H. P. WEBER
19914
12
Response: Breslow thickness and excision interval affect the activation state of Langerhans cells in melanoma sentinel lymph nodes
Blood ·Mari F.C.M. van den Hout, Bas D. Koster, Berbel J.R. Sluijter, Paul A.M. van Leeuwen, Sybren Meijer, M. Petrousjka van den Tol, Alfons J.M. van den Eertwegh, Rik J. Scheper, Rieneke van de Ven, Tanja D. de Gruijl
20123
13
Neurenterische Zyste des Mediastinums - Fallbericht und Literaturübersicht
Klinische Pädiatrie ·Bas D. Koster, D. Emons, U. Kunath, H. J. Födisch
19872
14
[Hemoglobin SD disease].
PubMed ·Laws Hj, R. Dickerhoff, Jean Mayer, Bas D. Koster
19931
15
[Mediastinal liposarcoma in a 14-year-old girl].
PubMed ·Bas D. Koster, Ulla Böde
19851
16
[Acute encephalopathy following cranial irradiation of previously treated meningeal leukemia].
PubMed ·U. Bode, Marion Diehl, Bas D. Koster
19861
17
High and interrelated rates of CD14+PD-L1+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer
A. Marijne Heeren, Bas D. Koster, Sanne Samuels, Debbie M. Ferns, Dafni Chondronasiou, Ekaterina J Jordanova, Gemma G. Kenter, Tanja D. de Gruijl
20141
18
Akute Isoniazid-Vergiftung
AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie ·Bas D. Koster, Ulla Böde, Hans Peter Weber, E. Musch
19851
19
Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread
Journal for ImmunoTherapy of Cancer ·Mari F.C.M. van den Hout, Bas D. Koster, Rik J. Scheper, Rieneke van de Ven, Berbel J.R. Sluijter, Barbara G. Molenkamp, Alfons J. van den Eertwegh, P.A. van Leeuwen, M. Petrousjka van den Tol, Tanja D. de Gruijl
20131

About Bas D. Koster

Bas D. Koster is a scholar working on Immunology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 19 papers that have together received 406 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (8 papers), T-cell and B-cell Immunology (3 papers), Cutaneous Melanoma Detection and Management (2 papers), Immune Cell Function and Interaction (2 papers), Glioma Diagnosis and Treatment (1 paper) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Immunology (280 citations), Oncology (273 citations), Obstetrics and Gynecology (24 citations), Cancer Research (29 citations) and Immunology and Allergy (10 citations). Bas D. Koster has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Tanja D. de Gruijl, Alfons J.M. van den Eertwegh, Ekaterina S. Jordanova, A. Marijne Heeren, Rik J. Scheper, Mari F.C.M. van den Hout, Barbara G. Molenkamp, Berbel J.R. Sluijter, Dafni Chondronasiou and Paul A.M. van Leeuwen. Their work appears in journals such as Cancer Immunology Research, Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer, Clinical Cancer Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jossie RotmanBreakdown of academic impact, for papers by Joyce M. LubbersBreakdown of academic impact, for papers by Mei CaoBreakdown of academic impact, for papers by Cécile DéjouBreakdown of academic impact, for papers by M. N. StakheyevaBreakdown of academic impact, for papers by Hila RazonBreakdown of academic impact, for papers by Valeria ViscontiBreakdown of academic impact, for papers by Diana HandkeBreakdown of academic impact, for papers by Boyeong SongBreakdown of academic impact, for papers by Apostolos C Ziogas